Research Article
Preparation and Characterization of a Gastric Floating Dosage Form of Capecitabine
Table 1
Different formulations of tablets with different concentrations (%).
| ā | HPMC | S.A | Car | S.B | Lac | PEG | Mg.St | Cap | Total |
| F1 | 20 | 20 | 1.6 | 13.3 | 35 | 6.6 | 3.3 | 150 | 300 | F2 | 20 | 20 | 3.3 | 13.3 | 33.3 | 6.6 | 3.3 | 150 | 300 | F3 | 20 | 20 | 4.6 | 13.3 | 32 | 6.6 | 3.3 | 150 | 300 | F4 | 16.6 | 16.6 | 3.3 | 13.3 | 40 | 6.6 | 3.3 | 150 | 300 | F5 | 16.6 | 20 | 3.3 | 13.3 | 36.6 | 6.6 | 3.3 | 150 | 300 | F6 | 16.6 | 23.3 | 3.3 | 13.3 | 33.3 | 6.6 | 3.3 | 150 | 300 | F7 | 20 | 16.6 | 3.3 | 13.3 | 36.6 | 6.6 | 3.3 | 150 | 300 | F8 | 20 | 20 | 3.3 | 13.3 | 33.3 | 6.6 | 3.3 | 150 | 300 | F9 | 20 | 23.3 | 3.3 | 13.3 | 30 | 6.6 | 3.3 | 150 | 300 | F10 | 23.3 | 16.6 | 3.3 | 13.3 | 33.3 | 6.6 | 3.3 | 150 | 300 | F11 | 23.3 | 20 | 3.3 | 13.3 | 30 | 6.6 | 3.3 | 150 | 300 | F12 | 23.3 | 23.3 | 3.3 | 13.3 | 26.6 | 6.6 | 3.3 | 150 | 300 |
|
|